Novel biomarkers: Help or hindrance to patient care in the emergency department?: Answers to the July 2010 journal club questions

Annals of Emergency Medicine

Volumn 56, Issue 6, 2010, Pages 692-700

  Self, Wesley H ^a,b   Barrett, Tyler W ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATININE; D DIMER; MITOCHONDRIAL RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TROPONIN;

ACUTE HEART INFARCTION; BAYES THEOREM; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; EMERGENCY CARE; EMERGENCY MEDICINE; EMERGENCY WARD; HEART FAILURE; HUMAN; IMMOBILIZATION; KIDNEY INJURY; LEUKOCYTE COUNT; LUNG EMBOLISM; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NOTE; PREDICTION; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; PROGNOSIS; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY;

EID: 78649503048     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2010.09.002     Document Type: Article

References (50)

1. N.I. Shapiro, S. Trzeciak, and J.E. Hollander The diagnostic accuracy of plasma neutrophil gelatinaseassociated lipocalin (NGAL) in the prediction of acute kidney injury in emergency department patients with suspected sepsis Ann Emerg Med 56 2010 52 59
2. M.A. Hlatky, P. Greenland, and D.K. Arnett Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association Circulation 119 2009 2408 2416
3. B.A. Molitoris, V.Y. Melnikov, and M.D. Okusa Technology insight: biomarker development in acute kidney injurywhat can we anticipate? Nat Clin Pract Nephrol 4 2008 154 165
4. Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 69 2001 89 95
5. Biomarkers Consortium Our vision http://www.thebiomarkersconsortium.org/ index.php?option=com-content&task=view&id=26&Itemid=47 Accessed June 10, 2010
6. S. Konstantinides Acute pulmonary embolism N Engl J Med 359 2008 2804 2813
7. J.A. Kline, D.M. Courtney, and C. Kabrhel Prospective multicenter evaluation of the pulmonary embolism rule-out criteria J Thromb Haemost 6 2008 772 780
8. A.M. Brown, and T.W. Barrett Journal club: outcome measures, interim analyses, and bayesian approaches to randomized trials Ann Emerg Med 54 2009 440 441
9. M.S. Runyon, D.M. Beam, and M.C. King Comparison of the Simplify D-dimer assay performed at the bedside with a laboratory-based quantitative D-dimer assay for the diagnosis of pulmonary embolism in a low prevalence emergency department population Emerg Med J 25 2008 70 75
10. J.A. Kline, A.M. Mitchell, and C. Kabrhel Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism J Thromb Haemost 2 2004 1247 1255
11. S.G. Pauker, and J.P. Kassirer The threshold approach to clinical decision making N Engl J Med 302 1980 1109 1117
12. R. Raynovich Biomarkers poised for breakout moment Genetic Engineering & Biotechnology News May 6, 2010 http://www.genengnews.com/analysis-and- insight/biomarkers-poised-for-breakout-moment/77899322 Accessed June 8, 2010
13. Centers for Disease Control and Prevention Breast cancer statistics http://www.cdc.gov/cancer/breast/statistics/index.htm Accessed June 9, 2010
14. D.A. Morrow, C.P. Cannon, and R.L. Jesse National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes Circulation 115 2007 e356 e375
15. L. Neergaard Overtreated: more medical care isn't always better Associated Press Medical Writer June 7, 2010 http://abcnews.go.com/Health/ wireStory?id=10843361 Accessed June 9, 2010
16. National Institutes of Health Clinical Trials.gov Web site http://www.clinicaltrials.gov/ct2/results?term= biomarker+AND+physician+AND+comparison Accessed June 16, 2010
17. M. Pfisterer, P. Buser, and H. Rickli BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) Randomized Trial JAMA 301 2009 383 392
18. S.P. Collins, S. Ronan-Bentle, and A.B. Storrow Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea Ann Emerg Med 41 2003 532 545
19. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
20. P.A. McCullough, R.M. Nowak, and J. McCord B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study Circulation 106 2002 416 422
21. D.M. Yealy, and M. Hsieh BNP is not a value-added routine test in the emergency department Ann Emerg Med 53 2009 387 389
22. D.B. Diercks, and C.D. Miller Natriuretic peptide testing: a useful diagnostic test Ann Emerg Med 53 2009 386 387
23. J.A. Kline, M.S. Runyon, and W.B. Webb Prospective study of the diagnostic accuracy of the simplify D-dimer assay for pulmonary embolism in emergency department patients Chest 129 2006 1417 1423
24. I. Boutron, S. Dutton, and P. Ravaud Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes JAMA 303 2010 2058 2064
25. A.K. Akobeng Understanding diagnostic tests 3: receiver operating characteristic curves Acta Paediatr 96 2007 644 647
26. D.A. Grimes, and K.F. Schulz Uses and abuses of screening tests Lancet 359 2002 881 884
27. T.W. Barrett, and D.L. Schriger Annals of Emergency Medicine Journal Club. Measures of emergency department crowding, odds ratios, and the dangers of making continuous data categorical Answers to January 2008 journal club questions Ann Emerg Med 51 2008 782 789
28. I. Ferreira-Gonzalez, G. Permanyer-Miralda, and A. Domingo-Salvany Problems with use of composite end points in cardiovascular trials: systematic review of randomized controlled trials BMJ 334 2007 786 10.1136/bmj.39136. 682083.AE Published online 2007 April 2
29. T.W. Barrett, and D.L. Schriger Annals of Emergency Medicine Journal Club Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment Answers to May 2008 journal club questions Ann Emerg Med 52 2008 458 472
30. W.A. Knaus, E.A. Draper, and D.P. Wagner APACHE II: a severity of disease classification system Crit Care Med 13 1985 818 829
31. K.M. Kuntz, K.E. Fleischmann, and M.G.M. Hunink Cost-effectiveness of diagnostic strategies for patients with chest pain Ann Intern Med 130 1999 709 718
32. L. Kjeldsen, A.H. Johnsen, and H. Sengelov Isolation and primary structure of NGAL, a novel protein associated with human neutrophil-gelatinase J Biol Chem 268 1993 10425 10432
33. T.H. Flo, K.D. Smith, and S. Sato Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron Nature 432 2004 917 921
34. J. Mishra, Q. Ma, and A. Prada Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal disease J Am Soc Nephrol 14 2003 2534 2543
35. J. Mishra, K. Mori, and Q. Ma Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin J Am Soc Nephrol 15 2004 3073 3082
36. J. Mishra, K. Mori, and Q. Ma Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity Am J Nephrol 24 2004 307 315
37. G. Wagener, M. Jan, and M. Kim Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery Anesthesiology 105 2006 485 491
38. J. Mishra, C. Dent, and R. Tarabishi Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery Lancet 365 2005 1231 1238
39. A. Aghel, K. Shrestha, and W. Mullens Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure J Card Fail 16 2010 49 54
40. K. Makris, N. Markou, and E. Evodia Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients Clin Chem Lab Med 47 2009 79 82
41. H. Bachorzewska-Gajewska, J. Malyszko, and E. Sitniewska Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions Am J Nephrol 26 2006 287 292 (Pubitemid 44121091)
42. D.S. Wheeler, P. Devarajan, and Q. Ma Serum neutrophil Gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock Crit Care Med 36 2008 1297 1303
43. C.U. Niemann, A. Walia, and J. Waldman Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin Liver Transpl 15 2009 1852 1860
44. T.L. Nickolas, M.J. O'Rourke, and J. Yang Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury Ann Intern Med 148 2008 810 819
45. D.N. Cruz, M. de Cal, and F. Garzotto Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population Intensive Care Med 36 2010 444 451
46. J.M. Constantin, E. Futier, and S. Perbet Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: a prospective study J Crit Care 25 2010 176 e1-6
47. M. Haase, R. Bellomo, and P. Devarajan Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in the diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis Am J Kidney Dis 54 2009 1012 1024
48. P. Kumpers, C. Hater, and A. Lukasz Serum neutrophil gelatinase- associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury Crit Care 14 2010 R9
49. N.I. Shapiro, S. Trzeciak, and J.E. Hollander A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock and death in emergency department patients with suspected sepsis Crit Care Med 37 2009 96 104
50. H.N. Yang, C.S. Boo, and M.G. Kim Urine neutrophil gelatinase-associated lipocalin: an independent predictor of adverse outcomes in acute kidney injury Am J Nephrol 31 2010 501 509